← Eichor
Study identifier: NCT04137133 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

Condition: Cystic Fibrosis  ·  Sponsor: University Hospital, Brest

PhaseNA
Planned participants20
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

The objective of this study is to evaluate the relevance of Porphyromonas as a biomarker predicting the risk of P. aeruginosa primocolonization in children form 0 to 18 years old with cystic fibrosis.

This description comes directly from the study's public registry record.

Talk to the study team

Geneviève HERY-ARNAUD  ·  0298145102  ·  Genevieve.Hery-Arnaud@univ-brest.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Fondation IldysRoscoff, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04137133